0000899243-22-013466.txt : 20220404
0000899243-22-013466.hdr.sgml : 20220404
20220404184831
ACCESSION NUMBER: 0000899243-22-013466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220401
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Korn Jerald
CENTRAL INDEX KEY: 0001782282
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35945
FILM NUMBER: 22804534
MAIL ADDRESS:
STREET 1: 128 GORDON RD
CITY: NEWTON
STATE: MA
ZIP: 02468
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Epizyme, Inc.
CENTRAL INDEX KEY: 0001571498
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261349956
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-229-5872
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-01
0
0001571498
Epizyme, Inc.
EPZM
0001782282
Korn Jerald
C/O EPIZYME, INC.
400 TECHNOLOGY SQUARE, 4TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
1.14
2022-04-01
4
A
0
800000
0.00
A
2032-03-31
Common Stock
800000
800000
D
This equity award was not granted pursuant to any pre-existing equity incentive plan of Epizyme, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
This option was granted on April 1, 2022 with respect to 800,000 shares of Common Stock of the Company, with 25% vesting on April 1, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
/s/ John Weidenbruch, attorney-in-fact
2022-04-04